当前位置： 阿仪网 > 生物试剂/抗体/细胞 > 细胞生物学 > 细胞/细胞株 > 上海富衡生物科技有限公司 > 产品展示 > 细胞库 > 人源细胞 > 人膀胱移行细胞癌细胞；T24(STR)FH0171
人膀胱移行细胞癌细胞；T24(STR)FH0171
价格：￥1400
品牌名称：富衡型号：FH0171 原产地：中国大陆 更新时间：2026/10/21 7:56:21
产品摘要：T24细胞系源自一位81岁白人女性的膀胱移行细胞癌组织。T24细胞是一种常用的人膀胱移行细胞癌（膀胱尿路上皮癌）研究模型，在膀胱癌的发病机制、药物筛选和治疗方法开发等研究中被广泛应用。
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：690
企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
61成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：3年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：629271
详细内容
| 产品名称 | 人膀胱移行细胞癌细胞；T24 (STR) |
|---|---|
| 品牌 | FuHeng |
| 英文名 | T24 (STR) |
| 货号 | FH0171 |
| 规格 | 1×10⁶cells/T25培养瓶 |
| 价格 | 1400.0 |
| 培养 | DMEM+10%FBS |
| 别称 | T-24; T 24 |
| 形态特征 | 上皮样 |
| 生长特性 | 贴壁生长 |
| 培养条件 | 气相：空气，95%；CO2,5%温度：37℃ |
| 传代方法 | 1：2传代 |
| 组织来源 | 膀胱移行上皮细胞 |
| 细胞简介 | 人膀胱移行细胞癌细胞 T24（STR）的组织来源是膀胱移行上皮细胞。 膀胱移行上皮细胞是覆盖在膀胱内表面的一种特殊细胞类型。当这些细胞发生癌变，就可能形成膀胱移行细胞癌，T24 细胞株就是从这类癌细胞中建立起来的。它具有膀胱移行细胞癌细胞的生物学特性，常被用于膀胱癌相关的基础研究，如癌症发生发展机制、药物筛选、肿瘤细胞生物学行为等方面的研究，以便更好地了解膀胱癌的病理生理过程，为膀胱癌的诊断、治疗和预防提供理论依据和实验基础。 |
| 特征特性 | 该细胞源自一位81岁白人女性患者的膀胱移行细胞癌组织；来源于移行细胞癌病人的白血病和血浆对T24和相关细胞株有细胞毒性；倍增时间为19小时；含ras(H-ras)癌基因,表达肿瘤特有抗原。 |
| 培养基 | T24完全培养基 |
富衡相关文献
| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| Dioscin initiates dual roles in bladder cancer progression via miR-195–5p/FASN/SLC3A2 axis-mediated cell death mechanisms | 10.1016/j.tranon.2025.102534 | 2025-09-16 | Translational Oncology | 4.1 | Yongchang Lai, Zhenping Peng, Zhaohui He, Zechao Lu, Shudan Yan, Qihong Nie, Yuke Xiang |
| Machine Learning and Experimental Validation Reveal MYH11 as a Novel Prognostic Biomarker and Therapeutic Target in Bladder Cancer | 10.2147/JIR.S519719 | 2025-06-26 | Journal of Inflammation Research | 4.1 | Zhiyong Tan, Xiaorong Chen, Shi Fu, Yinglong Huang, Haihao Li, Chen Gong, Dihao Lv, Chadanfeng Yang, Jiansong Wang, Mingxia Ding, Haifeng Wang |
| CircPGM5 regulates Foxo3a phosphorylation via MiR-21-5p/MAPK10 axis to inhibit bladder cancer progression | 10.1016/j.cellsig.2024.111297 | 2024-07-14 | CELLULAR SIGNALLING | 4.4 | Chao Cheng, Ze Zhang, Jiawei Wang, Chong Wang, Tiantian Liu, Chenglin Yang, Guowei Wang, Houbao Huang, Yawei Li |
| Encapsulation of hydroxycamptothecin within porous and hollow poly(L-lactide-co-ε-caprolactone) microspheres as a floating delivery system for intravesical instillation | 10.1039/D4BM00618F | 2024-06-11 | Biomaterials Science | 5.8 | Shiya Zhuang, Xingwei Jin, Lian Cen, Yuan Shao |
| Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation via Thiol–Maleimide Click Reaction for Intravesical Drug Delivery | 10.1021/acsabm.4c00068 | 2024-03-06 | ACS Applied Bio Materials | 4.6 | Fayang Li, Xianhuang Chen, Yuanqiao He, Zhiping Peng |
| Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage | 10.2174/0118715206274095231106042833 | 2024-03-01 | Anti-Cancer Agents in Medicinal Chemistry | 2.6 | Fan Ning, Zhang Lixiu, Wang Zhiping, Ding Hui, Yue Zhongjin |
| CircHIPK3 negatively regulates autophagy by blocking VCP binding to the Beclin 1 complex in bladder cancer | 10.1007/s12672-023-00689-0 | 2023-06-03 | Discover Oncology | 2.2 | Wang Chong, Liu Tiantian, Wang Jiawei, Cheng Chao, Zhang Ze, Zhang Jingwei, Huang Houbao, Li Yawei |
| µ-opioid receptor agonist facilitates circulating tumor cell ｆormation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial | 10.1002/cac2.12408 | 2023-02-05 | Cancer Communications | 16.2 | Xiaoqiang Wang, Song Zhang, Di Jin, Jiamei Luo, Yumiao Shi, Yiqi Zhang, Lingling Wu, Yanling Song, Diansan Su, Zhiying Pan, Haige Chen, Ming Cao, Chaoyong Yang, Weifeng Yu, Jie Tian |
| A Comparative Study of Fluoroquinolone-Resistant Escherichia coli Lineages Portrays Indistinguishable Pathogenicity- and Survivability-Associated Phenotypic Characteristics Between ST1193 and ST131 | 10.2147/IDR.S277681 | 2022-10-21 | Infection and Drug Resistance | 4.177 | Jiangqing Huang, Shengcen Zhang, Shuyu Zhang, Zhichang Zhao, Yingping Cao, Min Chen, Bin Li |
| BRD4 promotes the migration and invasion of bladder cancer cells through the Sonic hedgehog signaling pathway and enhances cisplatin resistance | 10.1139/bcb-2021-0552 | 2022-02-15 | Biochemistry and Cell Biology | 3.73 | Tiantian Liu, Ze Zhang, Chong Wang, Houbao Huang, Yawei Li |
| Epidemic Potential of Escherichia coli O16:H41-ST131: Compared with Pandemic O25b:H30-ST131 Lineage | 10.2147/IDR.S313261 | 2021-07-08 | Infection and Drug Resistance | 4.003 | Shengcen Zhang, Qianwen Zhang, Jiangqing Huang, Yingping Cao, Zhichang Zhao, Bin Li |
| Successive treatment with naltrexone induces epithelial–mesenchymal transition and facilitates the malignant biological behaviors of bladder cancer cells | 10.1093/abbs/gmaa169 | 2021-01-07 | ACTA BIOCHIMICA ET BIOPHYSICA SINICA | 3.848 | Wang Xiaoqiang, Zhang Ruirui, Wu Tong, Shi Yumiao, Zhou Xiao, Tang Dan, Yu Weifeng, So Edmund Cheung, Wu Xiaodan, Pan Zhiying, Tian Jie |
| Solute carrier family 12 member 8 (SLC12A8) is a potential biomarker and related to tumor immune cell infiltration in bladder cancer | 10.1080/21655979.2021.1962485 | 2021-01-01 | Bioengineered | 3.269 | Qian Zhang, Yunen Liu, Peng Chen, Xiuyun Shi, Ying Liu, Lin Shi, Peifang Cong, Shun Mao, Cangci Tong, Cheng Du, Mingxiao Hou |
| Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway | 10.12659/MSM.921087 | 2020-03-09 | MEDICAL SCIENCE MONITOR | 1.918 | Changlong Shi, Li Sun, Shaozhuang Liu, Enchong Zhang, Yongsheng Song |
热门标签：人膀胱移行细胞癌细胞,T24,T24细胞
